These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 8764029

  • 1. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
    Hanecak R, Brown-Driver V, Fox MC, Azad RF, Furusako S, Nozaki C, Ford C, Sasmor H, Anderson KP.
    J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029
    [Abstract] [Full Text] [Related]

  • 2. Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant.
    Zhang H, Hanecak R, Brown-Driver V, Azad R, Conklin B, Fox MC, Anderson KP.
    Antimicrob Agents Chemother; 1999 Feb; 43(2):347-53. PubMed ID: 9925530
    [Abstract] [Full Text] [Related]

  • 3. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH.
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [Abstract] [Full Text] [Related]

  • 4. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M, McHutchison JG, Kwoh TJ, Dorr FA, Pawlotsky JM.
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
    Brown-Driver V, Eto T, Lesnik E, Anderson KP, Hanecak RC.
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
    [Abstract] [Full Text] [Related]

  • 6. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
    Chiang MY, Chan H, Zounes MA, Freier SM, Lima WF, Bennett CF.
    J Biol Chem; 1991 Sep 25; 266(27):18162-71. PubMed ID: 1680858
    [Abstract] [Full Text] [Related]

  • 7. Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation.
    Alt M, Renz R, Hofschneider PH, Caselmann WH.
    Arch Virol; 1997 Sep 25; 142(3):589-99. PubMed ID: 9349305
    [Abstract] [Full Text] [Related]

  • 8. Oligonucleotide-based strategies to inhibit human hepatitis C virus.
    Martinand-Mari C, Lebleu B, Robbins I.
    Oligonucleotides; 2003 Sep 25; 13(6):539-48. PubMed ID: 15025918
    [Abstract] [Full Text] [Related]

  • 9. [Antisense oligonucleotide inhibition of coxsackievirus B3 gene expression in HeLa cells and dose-response experiments].
    Liu ZW, Sun HM, Xiao ZH, Qiu N, Zhang T, Zhao JM.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar 25; 18(1):62-5. PubMed ID: 15340530
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells.
    Mizutani T, Kato N, Hirota M, Sugiyama K, Murakami A, Shimotohno K.
    Biochem Biophys Res Commun; 1995 Jul 26; 212(3):906-11. PubMed ID: 7626129
    [Abstract] [Full Text] [Related]

  • 11. Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity.
    Lima WF, Brown-Driver V, Fox M, Hanecak R, Bruice TW.
    J Biol Chem; 1997 Jan 03; 272(1):626-38. PubMed ID: 8995306
    [Abstract] [Full Text] [Related]

  • 12. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
    McCaffrey AP, Meuse L, Karimi M, Contag CH, Kay MA.
    Hepatology; 2003 Aug 03; 38(2):503-8. PubMed ID: 12883495
    [Abstract] [Full Text] [Related]

  • 13. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs).
    Nulf CJ, Corey D.
    Nucleic Acids Res; 2004 Aug 03; 32(13):3792-8. PubMed ID: 15263060
    [Abstract] [Full Text] [Related]

  • 14. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C, Martin A, Caldarelli SA, Di Giorgio A, Condom R, Zoulim F, Durantel D, Hantz O.
    Antiviral Res; 2008 Dec 03; 80(3):280-7. PubMed ID: 18625270
    [Abstract] [Full Text] [Related]

  • 15. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.
    Seki M, Honda Y.
    J Biochem; 1995 Dec 03; 118(6):1199-204. PubMed ID: 8720135
    [Abstract] [Full Text] [Related]

  • 16. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.
    Vidalin O, Major ME, Rayner B, Imbach JL, Trépo C, Inchauspé G.
    Antimicrob Agents Chemother; 1996 Oct 03; 40(10):2337-44. PubMed ID: 8891141
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of dengue virus by novel, modified antisense oligonucleotides.
    Raviprakash K, Liu K, Matteucci M, Wagner R, Riffenburgh R, Carl M.
    J Virol; 1995 Jan 03; 69(1):69-74. PubMed ID: 7983769
    [Abstract] [Full Text] [Related]

  • 18. Antisense oligonucleotide inhibition of encephalomyocarditis virus RNA translation.
    Sankar S, Cheah KC, Porter AG.
    Eur J Biochem; 1989 Sep 01; 184(1):39-45. PubMed ID: 2476310
    [Abstract] [Full Text] [Related]

  • 19. The influence of downstream protein-coding sequence on internal ribosome entry on hepatitis C virus and other flavivirus RNAs.
    Rijnbrand R, Bredenbeek PJ, Haasnoot PC, Kieft JS, Spaan WJ, Lemon SM.
    RNA; 2001 Apr 01; 7(4):585-97. PubMed ID: 11345437
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
    González-Carmona MA, Quasdorff M, Vogt A, Tamke A, Yildiz Y, Hoffmann P, Lehmann T, Bartenschlager R, Engels JW, Kullak-Ublick GA, Sauerbruch T, Caselmann WH.
    Antiviral Res; 2013 Jan 01; 97(1):49-59. PubMed ID: 23142319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.